Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Treatment of a Severely Degenerated Mitral Bioprosthesis with Transcatheter Valve-In-Valve Implantation.

Chrissoheris M, Halapas A, Boumboulis N, Spargias K.

Hellenic J Cardiol. 2015 Jul-Aug;56(4):347-50. No abstract available.

2.

The Abbott Vascular MitraClip: Patient Selection and How to Obtain the Best Outcomes.

Chrissoheris M, Halapas A, Nikolaou I, Boumboulis N, Pattakos S, Spargias K.

Hellenic J Cardiol. 2015;56 Suppl A:31-8.

PMID:
26021341
3.

PorticoTM Transcatheter Heart Valve.

Tzikas A, Chrissoheris M, Halapas A, Spargias K.

Hellenic J Cardiol. 2015;56 Suppl A:15-9. No abstract available.

PMID:
26021339
4.

The SAPIEN-XT and SAPIEN-3 Valves: How to Implant and Obtain the Best Outcomes.

Halapas A, Chrissoheris M, Bouboulis N, Skardoutsos S, Nikolaou I, Pattakos S, Spargias K.

Hellenic J Cardiol. 2015;56 Suppl A:9-14. No abstract available.

PMID:
26021338
5.

The era of transcatheter valve therapy. Where are we?

Spargias K.

Hellenic J Cardiol. 2015;56 Suppl A:1-3. No abstract available.

PMID:
26021336
6.

Valvuloplasty with a paclitaxel-eluting balloon prevents restenosis in an experimental animal model of aortic stenosis.

Spargias K, Gyöngyösi M, Hemetsberger R, Posa A, Pavo N, Pavo IJ, Huber K, Petrasi Z, Petnehazy O, von Strandmann RP, Park J, Glogar D, Maurer G, Rajamannan NM.

J Heart Valve Dis. 2014 Jul;23(4):484-91.

PMID:
25803975
7.

Challenging transfemoral valve-in-valve implantation in a degenerated stentless bioprosthetic aortic valve.

Halapas A, Chrissoheris M, Spargias K.

J Invasive Cardiol. 2014 Aug;26(8):E106-8.

8.

Transaortic aortic valve replacement using the Edwards Sapien-XT Valve and the Medtronic CoreValve: initial experience.

Spargias K, Bouboulis N, Halapas A, Chrissoheris M, Skardoutsos S, Nikolaou J, Tsolakis A, Mourmouris C, Pattakos S.

Hellenic J Cardiol. 2014 Jul-Aug;55(4):288-93.

9.

Anesthetic management of patients undergoing transcatheter aortic valve implantation.

Balanika M, Smyrli A, Samanidis G, Spargias K, Stavridis G, Karavolias G, Khoury M, Voudris V, Lacoumenta S.

J Cardiothorac Vasc Anesth. 2014 Apr;28(2):285-9. doi: 10.1053/j.jvca.2013.07.010. Epub 2013 Dec 7.

PMID:
24315757
10.

Transapical closure of mitral prosthetic paravalvular leak.

Spargias K, Tzifa A, Chrissoheris M, Boumpoulis N, Nikolaou I, Pattakos E.

Hellenic J Cardiol. 2013 Sep-Oct;54(5):397-400.

11.

The Athens TAVR Registry of newer generation transfemoral aortic valves: 30-day outcomes.

Spargias K, Toutouzas K, Chrissoheris M, Synetos A, Halapas A, Paizis I, Latsios G, Stathogiannis K, Papametzelopoulos S, Zanos S, Pavlides G, Zacharoulis A, Antoniades A, Stefanadis C.

Hellenic J Cardiol. 2013 Jan-Feb;54(1):18-24. Erratum in: Hellenic J Cardiol. 2013 Mar-Apr;54(2):152. Stathogianni, Konstantinos [corrected to Stathogiannis, Konstantinos].

12.

Percutaneous mitral valve repair using the edge-to-edge technique: first Greek experience.

Spargias K, Chrissoheris M, Halapas A, Nikolaou J, Tsolakis A, Bouboulis N, Pattakos S.

Hellenic J Cardiol. 2012 Sep-Oct;53(5):343-51.

13.

Early prosthetic valve endocarditis complicating repeated attempts at CoreValve implantation.

Chrissoheris MP, Ferti A, Spargias K.

J Invasive Cardiol. 2011 Dec;23(12):E291-2.

14.

The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation.

Spargias K, Polymeros S, Dimopoulos A, Manginas A, Pavlides G, Balanika M, Smirli A, Stavridis G, Dangas G, Cokkinos DV.

J Interv Cardiol. 2011 Oct;24(5):462-9. doi: 10.1111/j.1540-8183.2011.00654.x. Epub 2011 Sep 2.

PMID:
21883470
15.

EBV Infection as a Cause of VT: Evaluation by CMR.

Mavrogeni S, Spargias K, Bratis C, Kolovou G, Papadopoulou E, Pavlides G.

JACC Cardiovasc Imaging. 2011 May;4(5):561-2. doi: 10.1016/j.jcmg.2010.11.022. No abstract available.

16.

Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study.

Mavrogeni S, Papavasiliou A, Spargias K, Constandoulakis P, Papadopoulos G, Karanasios E, Georgakopoulos D, Kolovou G, Demerouti E, Polymeros S, Kaklamanis L, Magoutas A, Papadopoulou E, Markussis V, Cokkinos DV.

BMC Neurol. 2010 May 21;10:33. doi: 10.1186/1471-2377-10-33.

17.

Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy.

Mavrogeni S, Spargias K, Markussis V, Kolovou G, Demerouti E, Papadopoulou E, Stavridis G, Kaklamanis L, Douskou M, Constantoulakis P, Cokkinos DV.

Inflamm Allergy Drug Targets. 2009 Dec;8(5):390-7.

PMID:
20025587
18.

Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.

Alexopoulos E, Spargias K, Kyrzopoulos S, Manginas A, Pavlides G, Voudris V, Lerakis S, McLean DS, Cokkinos DV.

Am J Med Sci. 2010 Jan;339(1):25-30. doi: 10.1097/MAJ.0b013e3181c06e70.

PMID:
19996728
19.

Percutaneous aortic valve implantation in patients with coronary artery disease: review of therapeutic strategies.

Dvir D, Assali A, Spargias K, Kornowski R.

J Invasive Cardiol. 2009 Dec;21(12):E237-41.

20.

Pulmonary arterial hypertension: many years' experience and modern approach to a malignant disease in a pulmonary hypertension centre.

Karyofillis P, Manginas A, Thomopoulou S, Balanos D, Spargias K, Cokkinos DV.

Hellenic J Cardiol. 2009 Nov-Dec;50(6):484-92.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk